Fig. 1From: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayFlow chart of patient inclusion. Patients sign informed consent prior to the molecular screening. If offered treatment in a cohort, the patients sign a drug specific informed consent before initiating treatmentBack to article page